Conventus Names New CEO

Conventus Orthopaedics Inc. has a pair of new leaders.

The Minneapolis, Minn.-based company has hired Paul Buckman as CEO and David Blue as chief commercial officer.

“Conventus Orthopaedics is well-prepared to commercialize a solution that we believe represents a true advance in the standard of care for treating peri-articular fractures,” said Paul Hindrichs, Conventus co-founder. “Paul and David have long track records of success and a wealth of industry experience that will serve Conventus well at this point in its evolution. Further, Paul has a deep understanding of our business as a result of serving as a member of our board of directors since its inception in 2009. Adding Paul and David to our leadership team is the right move for Conventus as we transform to a commercially driven company.”

Buckman has more than 30 years of leadership experience in the medical device and medical technology industry, holding executive level positions at SentreHEART Inc., Pathway Medical Technologies, St. Jude Medical Inc., ev3 (co-founder), Scimed/Boston Scientific Corp. and others. He has served on the board of directors for SentreHEART, Sunshine Heart Inc., Micro Therapeutics Inc., Velocimed Inc. (co-founder) and ev3.

Buckman earned his master’s degree in Business Administration and Finance, and a bachelor’s degree in Business Administration from Western Michigan University in Kalamazoo, Mich.

Blue has more than 30 years of commercial experience. He has spent significant time in leadership roles at startup companies, and previously served in senior level management positions at Zimmer Holdings Inc., Tornier, and DePuy Orthoaedics Inc. He has participated as an owner and partner in several orthopedic companies, including owning and running his own orthopedic distributorship.

Blue received a Bachelor of Arts degree in Business Administration from Augustana College in Sioux Falls, S.D.

Conventus Orthopaedics develops less invasive treatments for fractures and joint injuries.